title: Trends in the biosynthesis and production of the immunosuppressant tacrolimus (FK506).
abstract: The current off-patent state of tacrolimus (FK506) has opened the hunting season for new generic pharmaceutical formulations of this immunosuppressant. This fact has boosted the scientific and industrial research on tacrolimus for the last 5 years in order to improve its production. The fast discovery of tacrolimus producer strains has generated a huge number of producers, which presents the biosynthetic cluster of FK506 as a high promiscuous genetic region. For the first time, the current state-of-the-art on the tacrolimus biosynthesis, production improvements and drug purification is reviewed. On one hand, all the genes involved in the tacrolimus biosynthesis, in addition to the traditional PKS/NRPS, as well as their regulation are analysed. On the other hand, tacrolimus direct and indirect precursors are reviewed as a straight manner to improve the final yield, which is a current trend in the field. Twenty years of industrial and scientific improvements on tacrolimus production are summarised, whereas future trends are also drafted.
authors.affiliation: Instituto de Biotecnología de León (INBIOTEC), Parque Científico de León, Avda. Real, no 1, León, 24006, Spain, c.barreiro@unileon.es.
authors.forename: Carlos
authors.initials: C
authors.lastname: Barreiro
authors.forename: Miriam
authors.initials: M
authors.lastname: Martínez-Castro
mesh_terms: D053898:Biosynthetic Pathways / Q000235:genetics; D001709:Biotechnology / Q000379:methods* / Q000639:trends; D007166:Immunosuppressive Agents / Q000302:isolation & purification / Q000378:metabolism*; D013302:Streptomyces / Q000235:genetics* / Q000378:metabolism*; D016559:Tacrolimus / Q000302:isolation & purification / Q000378:metabolism*; D013678:Technology, Pharmaceutical / Q000379:methods* / Q000639:trends
chemical_list: D007166:Immunosuppressive Agents; D016559:Tacrolimus